News

A supplemental New Drug Application (sNDA) was submitted to FDA and an application for marketing authorization to the European Medicines Agency (EMA) for Nexavar. Bayer HealthCare executive committee

According to the agreement signed in 2007, the commencement of the study triggered €6.6m milestone payment from Janssen to Galapagos, which will conduct even Phase IIA studies. Designed

A Boehringer Ingelheim Group company, Pharmaton’s Ginsana adds manufacturing facilities and a line of six natural medicine brands besides worldwide distributor network to SFI. Ginsana’s products will continue

The acquired portfolio comprises a next-generation BMP, which is under development and has been designed to provide additional options to currently-marketed BMP products, as well as the rights

A $1m Healthcare Innovation Award has been formed to reward the healthcare innovations in decreasing child deaths in the developing countries. The organizations from the developing countries across

Produced under animal-origin free conditions, the first sugar-transferase is developed for in vitro sialylation of glycoproteins and complex molecules as human monoclonal antibodies (mAbs). The enzyme featuring high

Acebright specializes in the manufacturing of cancer and inflammatory drugs. NasVax will transfer all its rights to the two main technologies under development, namely an oral immunotherapy Anti-CD3

As per the terms of the agreement, Teva Pharmaceuticals will be an exclusive distributor of the verifi prenatal test in Israel, with all tests being carried out in

The company’s quality containers product line includes the CoolJarz Sealz products that feature threaded caps with a double-seal for better protection. Developed using pharmaceutical and medical-grade plastic interior,